Literature DB >> 12099771

Chronic cough and the cough reflex in common lung diseases.

T Higenbottam1.   

Abstract

Following the experience of asthma, characterised by the presence of bronchial hyper-responsiveness, the notion has been accepted that the chronic cough of disease occurs as a result of altered sensitivity of the afferent limb of the cough reflex. Methods for testing for the 'threshold' for eliciting the cough reflex have also been borrowed from asthma care. In the main aerosols are inhaled that contain the relevant stimulus.A number of factors influence the cough response to inhaled aerosols. The distribution of the inhaled aerosol is important as certain chemically sensitive receptors are distributed in different regions of the lungs. The larynx and central airways are important but so too are the peripheral airways. The degree of bronchodilatation is also important as airway narrowing can, itself, induce coughing in man.Asthma, oesophageal reflux and rhinitis patients experience increased coughing, that is associated with increased sensitivity to inhaled capsaicin. In syndromes of chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) increased sensitivity to coughing with capsaicin is common. This appears a specific effect of the pathogenic process of the disease. Modification of the disease process can lessen coughing and the sensitivity to capsaicin. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12099771     DOI: 10.1006/pupt.2002.0341

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  15 in total

1.  Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.

Authors:  David Richards; Joel R Gever; Anthony P Ford; Samuel J Fountain
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

2.  Authors' reply: Comment on: Monitoring treatment practices of childhood asthma in singapore: a questionnaire study.

Authors:  Daniel Yam Thiam Goh; Hugo P Van Bever
Journal:  Singapore Med J       Date:  2016-02       Impact factor: 1.858

3.  Automatic cough classification for tuberculosis screening in a real-world environment.

Authors:  Madhurananda Pahar; Marisa Klopper; Byron Reeve; Rob Warren; Grant Theron; Thomas Niesler
Journal:  Physiol Meas       Date:  2021-11-26       Impact factor: 2.833

Review 4.  Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Physiology (Bethesda)       Date:  2008-12

5.  Antitussive activity of sigma-1 receptor agonists in the guinea-pig.

Authors:  Claire Brown; Malika Fezoui; William M Selig; Carl E Schwartz; James L Ellis
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

Review 6.  Cough reflex sensitization from esophagus and nose.

Authors:  Michal Hennel; Mariana Brozmanova; Marian Kollarik
Journal:  Pulm Pharmacol Ther       Date:  2015-10-21       Impact factor: 3.410

7.  PCR based bronchoscopic detection of common respiratory pathogens in chronic cough: a case control study.

Authors:  Peter W West; Angela Kelsall; Samantha Decalmer; Winifred Dove; Paul W Bishop; James P Stewart; Ashley A Woodcock; Jaclyn A Smith
Journal:  Cough       Date:  2012-09-14

Review 8.  Transient receptor potential (TRP) channels in the airway: role in airway disease.

Authors:  M S Grace; M Baxter; E Dubuis; M A Birrell; M G Belvisi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

9.  COVID-19 cough classification using machine learning and global smartphone recordings.

Authors:  Madhurananda Pahar; Marisa Klopper; Robin Warren; Thomas Niesler
Journal:  Comput Biol Med       Date:  2021-06-17       Impact factor: 4.589

10.  Respiratory symptoms and peripheral airways disease in a cross-sectional study on a random population sample.

Authors:  Jan Yngve Olofson; Birgitta Houltz; Maria Nilsson Tengelin; Björn Bake
Journal:  BMJ Open       Date:  2012-11-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.